Surmodics (SRDX) News Today $41.44 -0.11 (-0.26%) (As of 07/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 October 2021 September 2021 August 2021 Time Period July 26 at 1:27 AM | americanbankingnews.comSurmodics (NASDAQ:SRDX) Research Coverage Started at StockNews.comJuly 26 at 1:25 AM | marketbeat.comSurmodics (NASDAQ:SRDX) Receives New Coverage from Analysts at StockNews.comStockNews.com started coverage on shares of Surmodics in a research report on Friday. They set a "hold" rating on the stock.July 21, 2024 | marketbeat.comSurmodics, Inc. (NASDAQ:SRDX) Shares Acquired by Acadian Asset Management LLCAcadian Asset Management LLC increased its position in Surmodics, Inc. (NASDAQ:SRDX - Free Report) by 11.3% in the first quarter, according to its most recent disclosure with the SEC. The institutional investor owned 408,779 shares of the company's stock after purchasing an additional 41,617 shareJuly 20, 2024 | americanbankingnews.comSurmodics (NASDAQ:SRDX) Now Covered by StockNews.comJuly 18, 2024 | marketbeat.comSurmodics (NASDAQ:SRDX) Coverage Initiated at StockNews.comStockNews.com started coverage on Surmodics in a research note on Thursday. They issued a "hold" rating on the stock.July 13, 2024 | marketbeat.comShort Interest in Surmodics, Inc. (NASDAQ:SRDX) Increases By 32.4%Surmodics, Inc. (NASDAQ:SRDX - Get Free Report) was the recipient of a large increase in short interest in the month of June. As of June 30th, there was short interest totalling 801,600 shares, an increase of 32.4% from the June 15th total of 605,500 shares. Currently, 5.9% of the company's stock are short sold. Based on an average daily trading volume, of 299,900 shares, the short-interest ratio is currently 2.7 days.July 9, 2024 | marketbeat.comSurmodics (NASDAQ:SRDX) Reaches New 52-Week High at $42.44Surmodics (NASDAQ:SRDX) Sets New 1-Year High at $42.44July 8, 2024 | globenewswire.comSTOCKHOLDER INVESTIGATION: The M&A Class Action Firm Investigates Merger of Surmodics, Inc. – SRDXJuly 3, 2024 | prnewswire.comSTOCKHOLDER ALERT: The M&A Class Action Firm Investigates Merger of Surmodics, Inc. - SRDXJune 28, 2024 | marketbeat.comSurmodics (NASDAQ:SRDX) Sees Unusually-High Trading VolumeSurmodics (NASDAQ:SRDX) Sees Strong Trading VolumeJune 24, 2024 | marketbeat.comStockNews.com Initiates Coverage on Surmodics (NASDAQ:SRDX)StockNews.com assumed coverage on Surmodics in a research report on Monday. They set a "hold" rating on the stock.June 11, 2024 | marketbeat.comSurmodics (NASDAQ:SRDX) Sees Large Volume IncreaseSurmodics (NASDAQ:SRDX) Sees Strong Trading VolumeJune 10, 2024 | businesswire.comSurmodics Awarded Thrombectomy Products Agreement with Premier, Inc.May 31, 2024 | marketbeat.comZacks Research Research Analysts Raise Earnings Estimates for Surmodics, Inc. (NASDAQ:SRDX)Surmodics, Inc. (NASDAQ:SRDX - Free Report) - Research analysts at Zacks Research boosted their Q3 2025 earnings per share (EPS) estimates for shares of Surmodics in a report released on Wednesday, May 29th. Zacks Research analyst D. Dey now forecasts that the company will earn $0.11 per share foMay 30, 2024 | marketbeat.comSurmodics (NASDAQ:SRDX) Downgraded to "Hold" at StockNews.comStockNews.com cut shares of Surmodics from a "buy" rating to a "hold" rating in a research note on Thursday.May 30, 2024 | marketbeat.comSurmodics (NASDAQ:SRDX) Receives "Market Perform" Rating from Barrington ResearchBarrington Research reiterated a "market perform" rating on shares of Surmodics in a report on Thursday.May 29, 2024 | prnewswire.comALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Surmodics, Inc.May 29, 2024 | marketbeat.comSurmodics' (SRDX) "Hold" Rating Reaffirmed at Lake Street CapitalLake Street Capital restated a "hold" rating and set a $43.00 price objective on shares of Surmodics in a report on Wednesday.May 29, 2024 | marketwatch.comSurmodics Shares Up in Premarket on $627M Go-Private Deal With GTCRMay 29, 2024 | msn.comHeico Posts Upbeat Earnings, Joins Surmodics, Abercrombie & Fitch And Other Big Stocks Moving Higher On WednesdayMay 29, 2024 | markets.businessinsider.comGTCR To Acquire Surmodics - Quick FactsMay 29, 2024 | tmcnet.comSRDX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Surmodics, Inc. Is Fair to ShareholdersMay 29, 2024 | msn.comSurmodics jumps 18% on acquisition by GTCRMay 29, 2024 | benzinga.comWhy Is Medical Coating Specialist Surmodics Trading Higher On Wednesday?May 29, 2024 | marketbeat.comSurmodics (NASDAQ:SRDX) Sets New 1-Year High at $42.36Surmodics (NASDAQ:SRDX) Hits New 52-Week High at $42.36May 29, 2024 | prnewswire.comShareholder Alert: Ademi LLP investigates whether Surmodics, Inc. has obtained a Fair Price for its Public ShareholdersMay 29, 2024 | businesswire.comSurmodics Enters into Definitive Agreement to be Acquired by GTCR for $43.00 Per Share in Cash, Representing an Approximate Equity Value of $627 MillionMay 24, 2024 | marketbeat.comSurmodics, Inc. (NASDAQ:SRDX) Forecasted to Earn Q3 2024 Earnings of ($0.31) Per ShareSurmodics, Inc. (NASDAQ:SRDX - Free Report) - Stock analysts at Zacks Research lowered their Q3 2024 EPS estimates for Surmodics in a research report issued on Wednesday, May 22nd. Zacks Research analyst D. Dey now expects that the company will earn ($0.31) per share for the quarter, down from thMay 23, 2024 | marketbeat.comFY2026 EPS Estimates for Surmodics, Inc. (NASDAQ:SRDX) Raised by AnalystSurmodics, Inc. (NASDAQ:SRDX - Free Report) - Analysts at Zacks Research raised their FY2026 EPS estimates for Surmodics in a research report issued to clients and investors on Wednesday, May 22nd. Zacks Research analyst D. Dey now anticipates that the company will post earnings of $0.32 per sharMay 22, 2024 | marketbeat.comPanagora Asset Management Inc. Boosts Stock Position in Surmodics, Inc. (NASDAQ:SRDX)Panagora Asset Management Inc. boosted its holdings in Surmodics, Inc. (NASDAQ:SRDX - Free Report) by 109.8% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 44,664 shares of the company's stock after acquiring an additional 23,379 shares during tMay 22, 2024 | marketbeat.comSurmodics (NASDAQ:SRDX) Share Price Crosses Above Two Hundred Day Moving Average of $32.01Surmodics (NASDAQ:SRDX) Shares Pass Above Two Hundred Day Moving Average of $32.01May 21, 2024 | finance.yahoo.comSurmodics, Inc.'s (NASDAQ:SRDX) Intrinsic Value Is Potentially 96% Above Its Share PriceMay 4, 2024 | finance.yahoo.comSurmodics, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen NextMay 2, 2024 | marketbeat.comSurmodics (NASDAQ:SRDX) Rating Reiterated by Barrington ResearchBarrington Research reissued an "outperform" rating and issued a $71.00 price objective on shares of Surmodics in a research note on Thursday.May 2, 2024 | marketbeat.comSurmodics (NASDAQ:SRDX) Releases Earnings Results, Beats Expectations By $0.43 EPSSurmodics (NASDAQ:SRDX - Get Free Report) released its quarterly earnings data on Wednesday. The company reported $0.07 earnings per share for the quarter, topping the consensus estimate of ($0.36) by $0.43. Surmodics had a return on equity of 8.06% and a net margin of 3.99%. The business had revenue of $31.96 million during the quarter, compared to analysts' expectations of $28.79 million. During the same quarter last year, the business posted ($0.40) EPS.May 2, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: CVS Health (CVS) and SurModics (SRDX)May 2, 2024 | finance.yahoo.comSurmodics Inc (SRDX) Q2 2024 Earnings Call Transcript Highlights: Robust Revenue Growth and ...May 1, 2024 | uk.finance.yahoo.comSurmodics, Inc. (SRDX) stock price, news, quote & history – Yahoo FinanceMay 1, 2024 | markets.businessinsider.comSurModics Outperforms with Raised Guidance and Strong Product Momentum: Buy Rating ReaffirmedMay 1, 2024 | marketbeat.comSurmodics (NASDAQ:SRDX) PT Lowered to $43.00Needham & Company LLC lowered their target price on shares of Surmodics from $47.00 to $43.00 and set a "buy" rating for the company in a research note on Wednesday.May 1, 2024 | investorplace.comSRDX Stock Earnings: Surmodics Beats EPS, Beats Revenue for Q2 2024May 1, 2024 | marketbeat.comSurmodics (NASDAQ:SRDX) Issues FY 2024 Earnings GuidanceSurmodics (NASDAQ:SRDX) updated its FY 2024 earnings guidance. The company provided EPS guidance of -0.670--0.470 for the period, compared to the consensus estimate of -0.940. The company also issued revenue guidance of $118.0 millionillion-$120.0 millionillion, compared to the consensus estimate of $119.7 millionillion.May 1, 2024 | businesswire.comSurmodics Reports Second Quarter of Fiscal Year 2024 Financial Results; Updates Fiscal Year 2024 Financial GuidanceApril 30, 2024 | markets.businessinsider.comSurModics earnings: here's what Wall Street expectsApril 30, 2024 | finance.yahoo.comCan the 4 Medical Device Stocks Hit Targets This Earnings Season?April 24, 2024 | marketbeat.comSurmodics (SRDX) Set to Announce Quarterly Earnings on WednesdaySurmodics (NASDAQ:SRDX) will be releasing earnings before the market opens on Wednesday, May 1, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=381142)April 19, 2024 | businesswire.comSurmodics to Report Second Quarter of Fiscal 2024 Financial Results on May 1April 17, 2024 | finance.yahoo.comWill SurModics (SRDX) Report Negative Q2 Earnings? What You Should KnowApril 16, 2024 | marketbeat.comSurmodics (NASDAQ:SRDX) Rating Increased to Strong-Buy at StockNews.comStockNews.com upgraded shares of Surmodics from a "buy" rating to a "strong-buy" rating in a report on Tuesday.April 13, 2024 | finance.yahoo.comInvestors in Surmodics (NASDAQ:SRDX) have unfortunately lost 54% over the last three years Get Surmodics News Delivered to You Automatically Sign up to receive the latest news and ratings for SRDX and its competitors with MarketBeat's FREE daily newsletter. Email Address “Generational Bull Run” Incoming (Ad)LIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event. You can find out what they are by clicking here now. SRDX Media Mentions By Week SRDX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SRDX News Sentiment▼0.750.62▲Average Medical News Sentiment SRDX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SRDX Articles This Week▼52▲SRDX Articles Average Week Get Surmodics News Delivered to You Automatically Sign up to receive the latest news and ratings for SRDX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Anika Therapeutics News Today Cytosorbents News Today Vapotherm News Today Alphatec News Today AtriCure News Today Orthofix Medical News Today AngioDynamics News Today Accuray News Today Rockwell Medical News Today ReShape Lifesciences News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SRDX) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredCollapse of the PetrodollarThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | Sponsored5 Stocks that could triple in a week Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Surmodics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Surmodics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
